Home Research COVID-19 Services Publications People Teaching Job Opening News Forum --> -->
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●DMFold ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 95 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 8wo5:A0 (7.4) BS01 peptide N/A N/A P16437 N/A
    2 8wo5:A0 (7.4) BS02 peptide N/A N/A P16437 N/A
    3 8wo5:A5 (7.4) BS01 peptide N/A N/A P26462 N/A
    4 8wo5:A6 (7.4) BS01 peptide N/A N/A P16437 N/A
    5 8wo5:A6 (7.4) BS02 peptide N/A N/A P16437 N/A
    6 8wo5:A7 (7.4) BS01 peptide N/A N/A P16437 N/A
    7 8wo5:A7 (7.4) BS02 peptide N/A N/A P16437 N/A
    8 8wo5:A8 (7.4) BS01 peptide N/A N/A P16437 N/A
    9 8wo5:A8 (7.4) BS02 peptide N/A N/A P16437 N/A
    10 8wo5:A9 (7.4) BS01 peptide N/A N/A P16437 N/A
    11 8wo5:A9 (7.4) BS02 peptide N/A N/A P16437 N/A
    12 8wo5:AA (7.4) BS01 peptide N/A N/A P16323 N/A
    13 8wo5:AA (7.4) BS02 peptide N/A N/A P16323 N/A
    14 8wo5:AB (7.4) BS01 peptide N/A N/A P16323 N/A
    15 8wo5:AC (7.4) BS01 peptide N/A N/A P16323 N/A
    16 8wo5:AC (7.4) BS02 peptide N/A N/A P16323 N/A
    17 8wo5:AE (7.4) BS01 peptide N/A N/A P16323 N/A
    18 8wo5:AV (7.4) BS01 peptide N/A N/A P15928 N/A
    19 8wo5:Ao (7.4) BS01 peptide N/A N/A P15928 N/A
    20 8wo5:B5 (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    21 8wo5:B5 (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    22 8wo5:BA (7.4) BS01 peptide N/A N/A P0A1I7 N/A
    23 8wo5:BA (7.4) BS02 peptide N/A N/A P0A1I7 N/A
    24 8wo5:BB (7.4) BS01 peptide N/A N/A P0A1I7 N/A
    25 8wo5:BC (7.4) BS01 peptide N/A N/A P0A1I7 N/A
    26 8wo5:BD (7.4) BS01 peptide N/A N/A P0A1I7 N/A
    27 8wo5:BE (7.4) BS01 peptide N/A N/A P0A1I7 N/A
    28 8wo5:BF (7.4) BS01 peptide N/A N/A P0A1I7 N/A
    29 8wo5:BV (7.4) BS01 peptide N/A N/A P15928 N/A
    30 8wo5:Ba (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    31 8wo5:Ba (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    32 8wo5:Bg (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    33 8wo5:Bg (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    34 8wo5:Bm (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    35 8wo5:Bm (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    36 8wo5:Bs (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    37 8wo5:Bs (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    38 8wo5:By (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    39 8wo5:By (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    40 8wo5:C6 (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    41 8wo5:C6 (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    42 8wo5:CA (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    43 8wo5:CA (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    44 8wo5:CG (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    45 8wo5:CG (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    46 8wo5:CM (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    47 8wo5:CM (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    48 8wo5:CS (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    49 8wo5:CS (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    50 8wo5:CY (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    51 8wo5:CY (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    52 8wo5:Ce (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    53 8wo5:Ce (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    54 8wo5:Ck (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    55 8wo5:Ck (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    56 8wo5:Cq (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    57 8wo5:Cq (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    58 8wo5:Cw (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    59 8wo5:Cw (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    60 8wo5:D1 (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    61 8wo5:D1 (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    62 8wo5:D7 (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    63 8wo5:D7 (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    64 8wo5:DB (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    65 8wo5:DB (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    66 8wo5:DD (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    67 8wo5:DD (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    68 8wo5:DJ (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    69 8wo5:DJ (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    70 8wo5:DQ (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    71 8wo5:DQ (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    72 8wo5:DW (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    73 8wo5:DW (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    74 8wo5:Dc (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    75 8wo5:Dc (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    76 8wo5:Di (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    77 8wo5:Di (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    78 8wo5:Do (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    79 8wo5:Do (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    80 8wo5:Du (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    81 8wo5:Du (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    82 8wo5:EE (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    83 8wo5:EE (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    84 8wo5:EK (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    85 8wo5:EK (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    86 8wo5:EQ (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    87 8wo5:EQ (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    88 8wo5:EW (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    89 8wo5:EW (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    90 8wo5:Ea (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    91 8wo5:Ea (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    92 8wo5:Eg (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    93 8wo5:Eg (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    94 8wo5:Em (7.4) BS01 peptide N/A N/A P0A1J9 N/A
    95 8wo5:Em (7.4) BS02 peptide N/A N/A P0A1J9 N/A
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • yangzhanglabumich.edu | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218